Apr 15, 2019 7:00am EDT Can-Fite Receives $1,000,000 Payment from CKD for Distribution of Namodenoson in South Korea
Apr 10, 2019 7:07am EDT Can-Fite Announces Late-Breaking Abstract Presentation on Namodenoson™ Phase II Results at the American Association of Clinical Oncology (ASCO) Annual Meeting
Mar 26, 2019 7:00am EDT Can-Fite Announces Phase II Advanced Liver Cancer Top-Line Results for its Orphan/Fast Track Drug Namodenoson
Feb 27, 2019 7:00am EST Can-Fite to Participate in Bio Asia International Conference on March 5-6, 2019 in Tokyo
Feb 25, 2019 7:00am EST Can-Fite Expands its Namodenoson Distribution Deal with CKD in South Korea with NASH Indication
Feb 04, 2019 7:00am EST Can-Fite Receives Notice of Allowance From U.S. Patent and Trademark Office for Osteoarthritis Drug
Jan 30, 2019 7:00am EST Can-Fite’s Drugs’ Potential Ability to Treat Cytokine Release Syndrome in Cancer Immunotherapy Published in Scientific Journal
